Specialties
Reports that name this provider
- Chemotherapy & Immunotherapy Quality in Japan
- Founded 1992; received ESMO Centre of Integrated Oncology and Palliative Care designation October 2018 (first Japanese institution to receive this distinction); receives more than 9,000 new patients per year; launched AI-partnered immunotherapy research program
- Oncologic Surgery Quality in Japan
- Department of Head and Neck Surgery performed 475 operations in FY 2023-24 including 109 endoscopic laryngo-pharyngeal surgery, 90 free flap reconstructions, 12 photoimmunotherapy, 13 endoscopic thyroid surgeries, 10 transoral robotic surgery; ESMO-accredited; CAP laboratory accreditation